GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Abbott Laboratories (MEX:ABT) » Definitions » ROE % Adjusted to Book Value

Abbott Laboratories (MEX:ABT) ROE % Adjusted to Book Value : 3.50% (As of Sep. 2024)


View and export this data going back to 1937. Start your Free Trial

What is Abbott Laboratories ROE % Adjusted to Book Value?

Abbott Laboratories's ROE % for the quarter that ended in Sep. 2024 was 17.24%. Abbott Laboratories's PB Ratio for the quarter that ended in Sep. 2024 was 4.92. Abbott Laboratories's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was 3.50%.


Abbott Laboratories ROE % Adjusted to Book Value Historical Data

The historical data trend for Abbott Laboratories's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott Laboratories ROE % Adjusted to Book Value Chart

Abbott Laboratories Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.37 2.43 2.99 3.66 3.04

Abbott Laboratories Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.31 3.55 2.61 3.03 3.50

Competitive Comparison of Abbott Laboratories's ROE % Adjusted to Book Value

For the Medical Devices subindustry, Abbott Laboratories's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abbott Laboratories's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Abbott Laboratories's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Abbott Laboratories's ROE % Adjusted to Book Value falls into.



Abbott Laboratories ROE % Adjusted to Book Value Calculation

Abbott Laboratories's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=14.18% / 4.66
=3.04%

Abbott Laboratories's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=17.24% / 4.92
=3.50%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Abbott Laboratories ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Abbott Laboratories's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Abbott Laboratories Business Description

Address
100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.